NO982006L - Terapeutisk preparat for transdermal tilf°rsel av virksomme stoffer gjennom huden - Google Patents
Terapeutisk preparat for transdermal tilf°rsel av virksomme stoffer gjennom hudenInfo
- Publication number
- NO982006L NO982006L NO982006A NO982006A NO982006L NO 982006 L NO982006 L NO 982006L NO 982006 A NO982006 A NO 982006A NO 982006 A NO982006 A NO 982006A NO 982006 L NO982006 L NO 982006L
- Authority
- NO
- Norway
- Prior art keywords
- skin
- active substances
- transdermal delivery
- therapeutic preparation
- transdermal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19541260A DE19541260A1 (de) | 1995-11-06 | 1995-11-06 | Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut |
PCT/EP1996/004138 WO1997017061A1 (de) | 1995-11-06 | 1996-09-21 | Therapeutische zubereitung zur transdermalen applikation von wirkstoffen durch die haut |
Publications (2)
Publication Number | Publication Date |
---|---|
NO982006D0 NO982006D0 (no) | 1998-05-04 |
NO982006L true NO982006L (no) | 1998-05-04 |
Family
ID=7776710
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO982006A NO982006L (no) | 1995-11-06 | 1998-05-04 | Terapeutisk preparat for transdermal tilf°rsel av virksomme stoffer gjennom huden |
Country Status (21)
Country | Link |
---|---|
US (1) | US6379696B1 (cs) |
EP (1) | EP0859595B1 (cs) |
JP (1) | JP2001507331A (cs) |
KR (1) | KR100445940B1 (cs) |
CN (1) | CN1201385A (cs) |
AT (1) | ATE186209T1 (cs) |
AU (1) | AU716896B2 (cs) |
CZ (1) | CZ289143B6 (cs) |
DE (2) | DE19541260A1 (cs) |
ES (1) | ES2141534T3 (cs) |
GR (1) | GR3032523T3 (cs) |
IL (1) | IL124279A (cs) |
MX (1) | MX9803563A (cs) |
MY (1) | MY132407A (cs) |
NO (1) | NO982006L (cs) |
NZ (1) | NZ318783A (cs) |
PL (1) | PL326497A1 (cs) |
PT (1) | PT859595E (cs) |
SK (1) | SK281405B6 (cs) |
WO (1) | WO1997017061A1 (cs) |
ZA (1) | ZA969271B (cs) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19830732B4 (de) * | 1998-07-09 | 2008-11-13 | Lts Lohmann Therapie-Systeme Ag | Zusammensetzung, enthaltend mindestens einen die Blutfettwerte beeinflussenden Wirkstoff und seine Verwendung |
DK1335711T3 (da) * | 2000-09-08 | 2007-11-26 | Alza Corp | Transdermal indretning |
US20020187169A1 (en) * | 2001-05-11 | 2002-12-12 | Shoujun Chen | Kavalactone compositions |
US7323191B2 (en) * | 2003-07-28 | 2008-01-29 | Alza Corporation | Transdermal warfarin system |
EP1731147A4 (en) * | 2004-03-31 | 2010-06-30 | Kowa Co | EXTERNAL PREPARATION |
WO2007125339A1 (en) | 2006-04-26 | 2007-11-08 | Rosemont Pharmaceuticals Ltd | Liquid oral compositions |
US7803778B2 (en) | 2006-05-23 | 2010-09-28 | Theracos, Inc. | Glucose transport inhibitors and methods of use |
US8748419B2 (en) | 2006-06-16 | 2014-06-10 | Theracos, Inc. | Treating obesity with muscarinic receptor M1 antagonists |
US7893053B2 (en) | 2006-06-16 | 2011-02-22 | Theracos, Inc. | Treating psychological conditions using muscarinic receptor M1 antagonists |
US7652767B2 (en) * | 2006-10-19 | 2010-01-26 | Sporian Microsystems, Inc. | Optical sensor with chemically reactive surface |
US20080152592A1 (en) * | 2006-12-21 | 2008-06-26 | Bayer Healthcare Llc | Method of therapeutic drug monitoring |
WO2008115224A2 (en) * | 2007-03-20 | 2008-09-25 | Bayer Healthcare Llc | Method of analyzing an analyte |
BRPI0809607A2 (pt) | 2007-04-02 | 2014-09-30 | Theracos Inc | Composto, composição farmacêutica, combinação farmacêutica, e, método para tratar uma doença |
BRPI0815708B8 (pt) | 2007-08-23 | 2021-05-25 | Theracos Sub Llc | composto, éster de pró-droga, composição farmacêutica, e, método para tratar uma doença ou condição |
US9061060B2 (en) | 2008-07-15 | 2015-06-23 | Theracos Inc. | Deuterated benzylbenzene derivatives and methods of use |
KR101654231B1 (ko) | 2008-08-22 | 2016-09-05 | 테라코스 서브, 엘엘씨 | Sglt2 억제제의 제조방법 |
CN102264743B (zh) | 2008-11-25 | 2015-02-11 | 罗彻斯特大学 | Mlk抑制剂及其使用方法 |
US8697661B2 (en) | 2009-06-24 | 2014-04-15 | Christine Kritikou | Use of spinosyns and spinosyn compositions against herpesviridae viral infections |
US11607407B2 (en) | 2010-04-13 | 2023-03-21 | Relmada Therapeutics, Inc. | Dermal pharmaceutical compositions of 1-methyl-2′,6′-pipecoloxylidide and method of use |
JP6086326B2 (ja) | 2010-05-24 | 2017-03-01 | ユニヴァーシティー オブ ロチェスター | 二環式ヘテロアリールキナーゼ阻害剤および使用方法 |
WO2011153712A1 (en) | 2010-06-12 | 2011-12-15 | Theracos, Inc. | Crystalline form of benzylbenzene sglt2 inhibitor |
US20160184340A1 (en) | 2010-12-22 | 2016-06-30 | Christine Kritikou | The use of spinosyns and spinosyn compositions as local anesthetics and as antiarrhythmic agents |
EP3502236B1 (en) | 2011-02-18 | 2023-08-23 | The Scripps Research Institute | Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate |
WO2014085795A1 (en) | 2012-11-30 | 2014-06-05 | University Of Rochester | Mixed lineage kinase inhibitors for hiv/aids therapies |
US9420820B2 (en) | 2013-08-09 | 2016-08-23 | University Of Tsukuba | Method for isolating polyphenols from olive mill water |
WO2015143240A2 (en) | 2014-03-19 | 2015-09-24 | Curza Global, Llc | Compositions and methods comprising 2-(acylamino)imidazoles |
WO2018184019A1 (en) | 2017-03-31 | 2018-10-04 | Curza Global, Llc | Compositions and methods comprising substituted 2-aminoimidazoles |
BR112021003156A2 (pt) | 2018-08-23 | 2021-05-11 | Seagen, Inc. | composição, anticorpo que se liga ao tigit humano, formulação farmacêutica, polinucleotídeo isolado, vetor, célula hospedeira, métodos para a produção de um anticorpo que se liga ao tigit humano e de anticorpos afucosilados que se ligam a tigit e para o tratamento de um câncer, e, kit. |
KR20230104659A (ko) | 2020-11-08 | 2023-07-10 | 씨젠 인크. | 면역 세포 억제제를 이용한 조합-요법 항체 약물 접합체 |
EP4320160A1 (en) | 2021-04-09 | 2024-02-14 | Seagen Inc. | Methods of treating cancer with anti-tigit antibodies |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3634016A1 (de) * | 1986-04-17 | 1987-10-29 | Lohmann Gmbh & Co Kg | Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung |
US5211947A (en) * | 1988-12-16 | 1993-05-18 | Schering Corporation | Method for lowering blood cholesterol levels with granulocyte-macrophage colony stimulating factor |
US5316765A (en) * | 1989-09-07 | 1994-05-31 | Karl Folkers Foundation For Biomedical And Clinical Research | Use of coenzyme Q10 in combination with HMG-CoA reductase inhibitor therapies |
ATE143603T1 (de) * | 1990-03-30 | 1996-10-15 | Yasunori Morimoto | Transdermal absorbierbares mittel mit morphin hydrochlorid |
IL109037A (en) * | 1993-03-19 | 1999-01-26 | Cellegy Pharma Inc | Preparations for causing phase separation of lipid layers and preparation of the above preparations |
DE4341444C2 (de) * | 1993-12-04 | 1996-03-14 | Lohmann Therapie Syst Lts | Wirkstoffhaltiges Pflaster und Verfahren zu seiner Herstellung |
US5968983A (en) * | 1994-10-05 | 1999-10-19 | Nitrosystems, Inc | Method and formulation for treating vascular disease |
-
1995
- 1995-11-06 DE DE19541260A patent/DE19541260A1/de not_active Withdrawn
-
1996
- 1996-09-21 CZ CZ19981366A patent/CZ289143B6/cs not_active IP Right Cessation
- 1996-09-21 ES ES96931820T patent/ES2141534T3/es not_active Expired - Lifetime
- 1996-09-21 EP EP96931820A patent/EP0859595B1/de not_active Expired - Lifetime
- 1996-09-21 WO PCT/EP1996/004138 patent/WO1997017061A1/de active IP Right Grant
- 1996-09-21 KR KR10-1998-0703316A patent/KR100445940B1/ko not_active IP Right Cessation
- 1996-09-21 NZ NZ318783A patent/NZ318783A/en unknown
- 1996-09-21 CN CN96198113A patent/CN1201385A/zh active Pending
- 1996-09-21 SK SK558-98A patent/SK281405B6/sk unknown
- 1996-09-21 AT AT96931820T patent/ATE186209T1/de active
- 1996-09-21 US US09/068,326 patent/US6379696B1/en not_active Expired - Lifetime
- 1996-09-21 IL IL12427997A patent/IL124279A/xx not_active IP Right Cessation
- 1996-09-21 PT PT96931820T patent/PT859595E/pt unknown
- 1996-09-21 JP JP51777797A patent/JP2001507331A/ja active Pending
- 1996-09-21 AU AU70859/96A patent/AU716896B2/en not_active Ceased
- 1996-09-21 DE DE59603597T patent/DE59603597D1/de not_active Expired - Lifetime
- 1996-09-21 PL PL96326497A patent/PL326497A1/xx unknown
- 1996-11-04 MY MYPI96004590A patent/MY132407A/en unknown
- 1996-11-05 ZA ZA969271A patent/ZA969271B/xx unknown
-
1998
- 1998-05-04 NO NO982006A patent/NO982006L/no not_active Application Discontinuation
- 1998-05-06 MX MX9803563A patent/MX9803563A/es not_active IP Right Cessation
-
2000
- 2000-01-31 GR GR20000400219T patent/GR3032523T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE59603597D1 (de) | 1999-12-09 |
ATE186209T1 (de) | 1999-11-15 |
SK281405B6 (sk) | 2001-03-12 |
ZA969271B (en) | 1997-06-03 |
MX9803563A (es) | 1998-09-30 |
IL124279A (en) | 2003-07-06 |
GR3032523T3 (en) | 2000-05-31 |
PT859595E (pt) | 2000-04-28 |
US6379696B1 (en) | 2002-04-30 |
KR19990067320A (ko) | 1999-08-16 |
KR100445940B1 (ko) | 2005-09-30 |
PL326497A1 (en) | 1998-09-28 |
ES2141534T3 (es) | 2000-03-16 |
SK55898A3 (en) | 1998-11-04 |
CZ289143B6 (cs) | 2001-11-14 |
EP0859595B1 (de) | 1999-11-03 |
DE19541260A1 (de) | 1997-05-07 |
CZ136698A3 (cs) | 1998-07-15 |
AU7085996A (en) | 1997-05-29 |
CN1201385A (zh) | 1998-12-09 |
NO982006D0 (no) | 1998-05-04 |
MY132407A (en) | 2007-10-31 |
EP0859595A1 (de) | 1998-08-26 |
WO1997017061A1 (de) | 1997-05-15 |
JP2001507331A (ja) | 2001-06-05 |
NZ318783A (en) | 1999-04-29 |
AU716896B2 (en) | 2000-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO982006L (no) | Terapeutisk preparat for transdermal tilf°rsel av virksomme stoffer gjennom huden | |
AU3984597A (en) | Formulation of 5-ht agonists | |
BR0312933A (pt) | Composição farmacêutica, unidade de dosagem farmacêutica, método para tratar uma ou mais doenças associadas com uma condição vascular, e, combinação terapêutica | |
WO2001027119A3 (de) | Substanzbibliothek enthaltend bicyclische imidazo-5-yl-amine und/oder bicyclische imidazo-3-yl-amine | |
YU59098A (sh) | Derivati spiro-piperidina, postupak njihovog dobijanja, njihova upotreba u proizvodnji leka korisnog za lečenje ili prevenciju bolova, upalnih procesa, migrene, povraćanja i postherpetične neuralgije i farmaceutski sastav koji ih sadrži | |
AU4597796A (en) | Steroid receptor modulator compounds and methods | |
AU3508497A (en) | Androgen receptor modulator compounds and methods | |
AU2002342765A1 (en) | Active ingredient combinations of polyhexamethylenebiguanidine hydrochloride and distearyldimethylammonium chloride and preparations comprising said active ingredient combinations | |
HK1068103A1 (en) | Selective androgen receptor modulators (sarms) for treating benign prostate hyperplasia | |
WO2004058717A8 (en) | Isoquinolinone derivatives and their use as therapeutic agents | |
DE69727922D1 (de) | Schnell zerfallende orale dosierungsform | |
BR0012136A (pt) | Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos | |
WO1999063976A3 (en) | Liver-selective glucocorticoid antagonist for treating diabetes | |
DK1063995T3 (da) | Kombination til behandling af alkoholafhængighed indeholdende en opiod-antagonist og en NMDA-receptorkompleks-modulator | |
WO2001001972A3 (en) | SELECTIVE iGluR5 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF MIGRAINE | |
DE69801660D1 (de) | Lokale behandlung von psoriasis unter verwendung neutralisierender antikörper gegen il-8 | |
EP1064966A3 (en) | Combination of an 5HT1 receptor antagonist, caffeine and a cyclooxygenase-2 inhibitor for the treatment of migraine | |
WO1998026770A3 (en) | The topical use of kappa opioid agonists to treat ocular pain | |
MY124480A (en) | Use of glyceryl triacetate for treating onychomycoses | |
AU2002321232A1 (en) | Treatment of hair follicle with neurokinin 1 receptor antagonists | |
WO2000001415A3 (en) | Use of inhibitors of protein kinase c epsilon to treat pain | |
ES2088128T3 (es) | Aminosulfonilureas inhibidoras de acat. | |
PT855916E (pt) | Composicao farmaceutica contendo um estimulador de activina ou inibina | |
MX9601149A (es) | Uso de un antagonista del peptido derivado del gen de calcitonina para el tratamiento del prurito y de las disestesias oculares o palpebrales y composicion que incluye dicho antagonista. | |
DE69626544D1 (de) | Arzneistoffe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |